A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Hairy Cell Leukemia

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Dana Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Eric Winer, MD) · 617-632-6876
  • Mayo Clinic Cancer Center, Rochester, Minnesota, United States

    Contact: Study coordinator (Sameer Parikh, M.B.B.S.) · 507-218-0772
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Jae Park, MD) · 646-608-3743
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

    Contact: Study coordinator (Jae Park, MD) · 646-608-3743
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

    Contact: Study coordinator (Jae Park, MD) · 646-608-3743
  • Memorial Sloan Kettering Cancer Commack - Suffolk (Limited Protocol Activities), Commack, New York, United States

    Contact: Study coordinator (Jae Park, MD) · 646-608-3743
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison, New York, United States

    Contact: Study coordinator (Jae Park, MD) · 646-608-3743
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

    Contact: Study coordinator (Jae Park, MD) · 646-608-3743
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States

    Contact: Study coordinator (Jae Park, MD) · 646-608-3743
  • Ohio State University, Columbus, Ohio, United States

    Contact: Study coordinator (Michael Grever, MD) · 614-293-3196
    Contact: Principal Investigator (Michael Grever, MD)
מובילי המחקר
  • Jae Park, MD

    Principal Investigator

    Memorial Sloan Kettering Cancer Center